Financing type:  bought deal prospectus offering

Gross proceeds:  $38,007,523

Offering:  52,065,100 listed shares

Offering price:  73 cents per listed share

Overallotment option:  The underwriters may purchase a maximum of 6,791,100 listed shares for overallotment purposes, at any time until 30 days following the closing date. As of April 2, 2026, such option has been fully exercised. All information presented herein includes such exercise.

Disclosure:  Refer to the prospectus dated March 4 2026, and the company's news releases dated Feb. 19, 2026, Feb. 20, 2026, March 4, 2026, March 10, 2026, and March 18, 2026.